Veriskin
Veriskin - TruScore Cancer Screening Device.
Launch date
Market cap
-
Enterprise valuation
AUD6—9m (Dealroom.co estimates May 2021.)
San Diego California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $2.0m | Grant | |
| N/A | N/A | - | |
$1.0m | Seed | ||
$3.9m | Grant | ||
| Total Funding | AUD10.7m | ||